Antiviral efficacy versus host recovery: contrasting transcriptional footprints of four antivirals in human cytomegalovirus-infected brain organoids

This study demonstrates that while four antivirals reduce human cytomegalovirus load in infected brain organoids, they exhibit distinct efficacy profiles and differential impacts on host transcriptional recovery, with ganciclovir and letermovir emerging as promising candidates for mitigating neural damage in congenital HCMV infection.

The Gist

Imagine a bustling city (your brain organoid) that gets invaded by a group of unruly squatters (the Human Cytomegalovirus, or HCMV). In a healthy city, these squatters usually stay quiet and cause no trouble. But if they move in while the city is still being built (during fetal development), they can cause serious damage to the infrastructure.

To fix this, the city managers usually call in a cleanup crew called Ganciclovir. Sometimes, they try Maribavir or Letermovir as alternatives. However, until now, nobody had really checked which crew not only kicks the squatters out best but also helps the city return to its normal, peaceful state without causing new problems.

The researchers in this study set up a simulation: they let the squatters into a model of a human brain and then sent in four different cleanup crews to see how they performed over two weeks. The four crews were:

1. Aciclovir
2. Ganciclovir
3. Letermovir
4. Maribavir

Here is what they found, using some simple comparisons:

The "Squatter Removal" Scorecard
Think of the virus as a pile of trash. The goal is to get rid of as much trash as possible.

• Aciclovir was the weakest cleaner, removing only about 3 times less trash than doing nothing.
• Maribavir did better, removing about 7 times less trash.
• Ganciclovir (the usual choice) was strong, removing about 20 times less trash.
• Letermovir was the superstar, removing a massive 65 times less trash.

The "City Noise" Scorecard
But cleaning up the trash isn't the only goal. The researchers also listened to the "noise" of the city—the thousands of instructions (genes) the cells were shouting out. When the squatters arrived, the city went into panic mode, shouting about "neurodevelopmental stress" and "metabolic chaos."

• Aciclovir, Ganciclovir, and Maribavir were like quiet janitors. They removed some trash, but they didn't change the city's noise much. The cells were still shouting in a slightly chaotic way, similar to how they were before the cleaners arrived.
• Letermovir, however, was a loudspeaker. While it removed the most trash, it also changed the city's noise significantly. It turned down the panic but started a new, specific conversation about energy and fuel (glycolysis). It was the only one that made a big, noticeable shift in how the cells were talking to each other.

The Big Picture
The study concludes that choosing a cleanup crew isn't just about who kicks the squatters out the fastest. It also changes how the city feels afterward.

• Ganciclovir and Letermovir seem to be the most effective at clearing the virus.
• However, Letermovir leaves a distinct "footprint" on the brain cells' activity, specifically regarding how they use energy.

The authors suggest that because these drugs affect the brain's internal "conversation" differently, doctors should look closely at Ganciclovir and Letermovir when trying to heal the developing brain from this specific infection. They are the top contenders for not just stopping the virus, but also helping the brain recover its normal rhythm.

Technical Summary

Technical Summary

Problem Statement
Human cytomegalovirus (HCMV) infection is typically asymptomatic in healthy adults but poses a severe risk of neurological injury following congenital transmission. While ganciclovir remains the standard treatment for symptomatic congenital infection, with maribavir and letermovir serving as alternative direct-acting agents, there is a lack of direct comparative assessment regarding their efficacy. Specifically, it is unclear how these agents differ not only in their ability to clear the virus but also in their capacity to restore the host's transcriptional profile to an uninfected state within a relevant neural model.

Methodology
To address these gaps, the study utilized human cerebral organoids infected with the Merlin strain of HCMV. The experimental design involved a 14-day treatment period where infected organoids were exposed to one of four antivirals: aciclovir, ganciclovir, letermovir, or maribavir. These treated groups were compared against untreated infected organoids (NO). The researchers employed RNA-seq to quantify viral load and assess host transcriptional changes. The analysis included the identification of differentially expressed genes (DEGs) between infected and uninfected states, followed by functional enrichment analysis using Gene Ontology (GO), KEGG, and MSigDB Hallmark pathways. The study also integrated new data with existing datasets to establish a baseline of over 2,500 DEGs associated with HCMV infection.

Key Results
All four antivirals demonstrated a reduction in HCMV RNA-seq reads compared to untreated infected organoids, yet they exhibited distinct profiles regarding viral clearance and host transcriptional recovery:

• Viral Load Reduction: The magnitude of viral reduction varied significantly among the drugs. Letermovir achieved the highest reduction (65.4-fold), followed by ganciclovir (20.1-fold), maribavir (6.9-fold), and aciclovir (3.3-fold).
• Host Transcriptional Impact:
  • Aciclovir, Ganciclovir, and Maribavir: These agents resulted in few differentially expressed host genes relative to the untreated infected state. Consequently, they showed no significant Gene Ontology or KEGG pathway enrichment.
  • Letermovir: In contrast, letermovir treatment altered 312 host genes. These changes were enriched for glycolysis and related metabolic processes.
• Pathway-Level Analysis: MSigDB Hallmark pathway analysis revealed minimal perturbation with aciclovir and letermovir. Conversely, ganciclovir and maribavir induced small but coordinated pathway-level shifts. These shifts were partially aligned with the direction of control uninfected organoids but also included additional perturbations not observed in the controls.
• Infection Signature: The study confirmed that HCMV infection in organoids enriches for neurodevelopmental and metabolic stress pathways, identifying over 2,500 differentially expressed host genes in infected versus uninfected conditions.

Significance and Claims
The paper concludes that the choice of antiviral therapy influences both the clearance of HCMV and the transcriptional state of infected neural tissue. The findings suggest that while all tested drugs reduce viral load, they do not uniformly restore the host transcriptional landscape. Specifically, the results support the further evaluation of ganciclovir and letermovir for the therapy of neural damage resulting from HCMV infection, with a particular focus on the developing fetal brain. The study emphasizes that effective treatment requires balancing antiviral efficacy with the minimization of host transcriptional disruption.